NEW DELHI, Apr 23: Drug Controller General of India (DGCI) on Friday gave approval for the emergency use of Zydus's ‘Virafin’ in treating moderate COVID-19 infection in adults.
Cadila Health said one dose of Pegylated Interferon Alpha-2b, ‘Virafin’ showed clinical and virological improvement in moderate COVID-19 cases. It said the treatment significantly reduces the hours of supplemental oxygen in the patients.
When administered early on during COVID-19, Virafin will help patients recover faster and avoid much of the complications. It will be available on the prescription of a medical specialist for use in a hospital/institutional setup.
|